Monday, July 23, 2018
 
 
Company News: Page (1) of 1 - 01/10/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
IPatientCare Once Again Receives a Designation of Qualified Registry for MIPS for the Year 2018 by CMS
 
(January 10, 2018)
IPatientCare Once Again Receives a Designation of Qualified Registry for MIPS for the Year 2018 by CMS

iPatientCare, a pioneer in cloud-based ambulatory EHR and Revenue Cycle Management services, stated its approval as a Qualified Registry for MIPS by the Centers for Medicare and Medicaid Services (CMS) for the year 2018. The eligible providers will be able to submit their data directly to the CMS with the help of iPatientCare MIPS reporting service.

Now physicians can participate, report MIPS as individual or as a group, and track how they are meeting a particular quality metric by reporting on MIPS measures. MIPS adjusts payment based on performance from two years prior (e.g., performance in 2018 determines payment adjustments in 2020).

iPatientCare's MIPS Reporting Registry is an easy-to-use solution for seamlessly reporting data for all the MIPS Performance categories – Quality, improvement Activities and Advancing Care Information. iPatientCare has also introduced its MIPS Calculator which allows physicians to calculate their MIPS score at any given point in time.



iPatientCare is nominated as a Qualified Registry for MIPS 2018 by the CMS. It is a moment of pride and honor for us to serve the physicians and assist them in meeting MACRA requirements. “Doctors really need help in getting ready for the current and upcoming years. We have always been helping our clients to analyze, collect and report data pertaining to the quality of care and are pleased to provide them the option of Registry," said Arnaz Bharucha, Sr. Technology Officer, iPatientCare.

iPatientCare has been a qualified PQRS registry since year 2014, and have helped many physician practices to increase their revenues while improving patient care. Now with this achievement of being Qualified Registry for MIPS again for year 2018, iPatientCare is looking forward to helping physician community in improving care quality and staying compliant.

About iPatientCare:

Based at Woodbridge, New Jersey, iPatientCare is a private-held Corporation that is nationally recognized as one of the leading companies providing EHR and integrated MACRA-ready solutions and intelligent medical billing and revenue cycle enhancement services to physician offices providing primary and specialty care, rural health clinics, and community/federally qualified health centers (CHC/FQHC) nationwide.

At iPatientCare, we help healthcare providers dramatically reduce A/R days and improve collections rates, reduce billing costs, eliminate the burden of repeatable, high volume work on their internal teams, and plug gaps in staffing and internal bandwidth. Our expert teams are comprised of senior executives with extensive experience in clinically-driven revenue cycle management systems including certified billers and coders with managerial capabilities to facilitate client interactions, escalations and SLA. We also provide a dedicated account manager and a team of talented experts assigned to work as an extension of your office, instead of operating as an outsourced billing company or technology vendor.

iPatientCare EHR 2014 (2.0) has received 2014 Edition Ambulatory Complete EHR certification by ICSA Labs, an Office of the National Coordinator-Authorized Certification Body (ONC-ACB), in accordance with the applicable eligible professional certification criteria adopted by the Secretary of Health and Human Services (HHS). Full certification details can be found at ONC Certified Health IT Product List. Moreover, now iPatientCare EHR 18.0 has received 2015 Edition ONC Health IT certification by Drummond Group, an Office of the National Coordinator-Authorized Certification Body (ONC-ACB), in accordance with the applicable eligible professional certification criteria adopted by the Secretary of Health and Human Services (HHS). Full certification details can be found at ONC Certified Health IT Product List. If desired, we make the difficult tasks of revenue cycle optimization and MACRA/PCMH/QR reporting easier by bundling innovative EHR and other cloud-based practice solutions as part of our revenue cycle management and MACRA consulting services at no additional costs.

As part of its MACRA-ready solutions, iPatientCare has been recognized as a qualified MACRA-MIPS registry for the year 2017 by CMS, and has a distinguished credit of being selected as a preferred EHR vendor and medical/chiropractic billing company by more than 70,000 users nationwide, numerous hospitals/health systems, federally funded regional extension centers, and in the past by the US Army and NASA Space Medicine.

Visit http://www.iPatientCare.com for more information.

Read the full story at http://www.prweb.com/releases/2018/01/prweb15069432.htm.


Page: 1


Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Vision Care Product Market To Witness Enhanced Growth Owing To Rising Occurrence Of Eye Disorders Till 2021 | Million Insights
  • Global Prosthetic Heart Valve Market Reaching at a CAGR of +12.70% by Geography, Deployment Model, Component, and Key players are Boston Scientific Cardiology, CryoLife, Inc., Abbott
  • Trauma Fixation Global Market to Register Steady Expansion During 2018-2025
  • Global Surgical Apparel Market Will Reach USD 2,966.58 million by 2024: Zion Market Research

    Cancer
  • CStone Pharmaceuticals Appoints Former Goldman Sachs Executive Richard Yeh as CFO
  • HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
  • Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody
  • Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia
  • Mesothelioma is a Deadly Cancer and it’s Completely Preventable
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines